Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
84.68B | 86.15B | 79.18B | 64.22B | 44.65B | Gross Profit |
56.77B | 59.28B | 54.20B | 43.77B | 28.55B | EBIT |
18.90B | 22.55B | 21.00B | 17.04B | 8.11B | EBITDA |
23.44B | 25.14B | 26.10B | 22.53B | 12.52B | Net Income Common Stockholders |
5.21B | 6.30B | 5.80B | 4.95B | 1.93B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
13.77B | 11.48B | 11.23B | 10.67B | 21.11B | Total Assets |
146.34B | 140.87B | 131.95B | 122.36B | 106.02B | Total Debt |
40.79B | 38.46B | 35.16B | 34.47B | 37.85B | Net Debt |
31.03B | 30.54B | 27.57B | 26.35B | 17.49B | Total Liabilities |
79.49B | 80.58B | 77.64B | 75.99B | 69.77B | Stockholders Equity |
24.29B | 21.53B | 6.16B | 15.37B | 11.27B |
Cash Flow | Free Cash Flow | |||
13.39B | 10.59B | 12.86B | 15.39B | 8.42B | Operating Cash Flow |
18.92B | 18.40B | 17.83B | 18.65B | 10.88B | Investing Cash Flow |
-6.54B | -8.31B | -5.92B | -17.11B | -3.11B | Financing Cash Flow |
-10.73B | -9.54B | -12.49B | -14.32B | 7.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $255.33B | 56.16 | 28.67% | 0.98% | 12.98% | 6.62% | |
75 Outperform | €247.70B | 19.73 | 19.53% | 2.67% | -1.71% | -17.20% | |
71 Outperform | €82.05B | 15.75 | 22.73% | 2.86% | -1.71% | -17.39% | |
67 Neutral | €111.38B | 46.97 | 6.00% | 1.62% | 4.38% | 1.71% | |
62 Neutral | €21.51B | 18.99 | 7.52% | 6.56% | -12.12% | -62.09% | |
61 Neutral | $6.66B | 11.77 | 3.06% | 3.96% | 2.60% | -21.54% |